Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 5/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | BAD | Q92934 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 2/20 | 0.36 |
| ▸ | KDR | P35968 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14196553 | 1.00 | CHEK1 (0.39) | CHEK1BCL2L1BADNFE2L2TRPA1 | |
| SCHEMBL14196535 | 0.97 | NFE2L2 (0.39) | CHEK1BCL2L1BADNFE2L2TRPA1 | |
| SCHEMBL14196539 | 0.96 | NFE2L2 (0.40) | CHEK1BCL2L1BADNFE2L2TRPA1 | |
| SCHEMBL14196549 | 0.93 | NFE2L2 (0.42) | CHEK1BCL2L1BADNFE2L2TRPA1 | |
| SCHEMBL14196523 | 0.93 | NFE2L2 (0.42) | CHEK1BCL2L1BADNFE2L2TRPA1 | |
| SCHEMBL14196537 | 0.91 | NFE2L2 (0.43) | CHEK1BCL2L1BADNFE2L2TRPA1 | |
| SCHEMBL14196554 | 0.91 | NFE2L2 (0.43) | CHEK1BCL2L1BADNFE2L2TRPA1 | |
| SCHEMBL14196536 | 0.91 | NFE2L2 (0.43) | CHEK1BCL2L1BADNFE2L2TRPA1 | |
| SCHEMBL14196526 | 0.87 | NFE2L2 (0.36) | CHEK1BCL2L1BADNFE2L2TRPA1 | |
| SCHEMBL14196513 | 0.86 | RELA (0.40) | CHEK1NFE2L2RELAAPPKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8911882-B2 | Stilbene derivative, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-12-16 | — | — | US | disclosed |
| US-8911882-B2 | Stilbene derivative, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-12-16 | — | — | US | disclosed |
| US-20080088229-A1 | Stilbene Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-04-17 | — | — | US | disclosed |
| US-20080088229-A1 | Stilbene Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080088229-A1 | Stilbene Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device | HSF1, HSPA1B, HSPB1 | CHEK1 2616/4885BCL2L1 1581/4885BAD 4410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.